Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex

Synapse

Volumn 24, Issue 1, 1996, Pages 12-18

  Pehek, Elizabeth A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

5 HT2 receptor; 5 HT3 4 receptor; Antipsychotic drugs; Microdialysis; Schizophrenia

Indexed keywords

CLOZAPINE; RITANSERIN; SEROTONIN; SEROTONIN RECEPTOR; TROPISETRON;

ARTICLE; DIALYSIS; DOPAMINE RELEASE; EFFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; NERVE ENDING; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION;

ANIMALS; DOPAMINE; INDOLES; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RITANSERIN; SEROTONIN ANTAGONISTS;

EID: 0029809349     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199609)24:1<12::AID-SYN2>3.0.CO;2-J     Document Type: Article

References (63)

1. Abercrombie, E.D., Keefe, K.A., DeFrischia, D.S., and Zigmond, M.J. (1989) Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial prefrontal cortex. J. Neurochem., 52:1655-1658.
2. Adell, A., and Artigas, F. (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nucleus and frontal cortex. Naunyn Schmiedebergs Arch. Pharmacol., 343:237-244.
3. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience, 40:399-412.
4. Ashby, C.R., and Wang, R.Y. (1990) Effects of antipsychotic drugs on 5-HT2 receptors in the medial prefrontal cortex: Microiontophoretic studies. Brain Res., 506:346-348.
5. Bannon, M.J., and Roth, R.H. (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev., 35:53-68.
6. 3H]-(S)-Zacopride in the forebrain of the rat. Neuropharmacology, 29:1037-1045.
7. Benloucif, S., and Galloway, M.P. (1991) Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis. Eur. J. Pharmacol., 200:1-8.
8. Benloucif, S., Keegan, M. J., and Galloway, M.P. (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther., 265:373-377.
9. 3 receptors in rat striatum. J. Pharmacol. Exp. Ther., 251: 803-809.
10. 3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol., 164:515-519.
11. Chen, J., Van Praag, H.M., and Gardner, E.L. (1991) Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res., 543:354-357.
12. Chen, J., Paredes, W., Van Praag, H.M., Lowinson, J.H., and Gardner, E.L. (1992) Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse, 10:264-266.
13. Chiodo, L.A., Bannon, M.J., Grace, A.A., Roth, R.H., and Bunney, B.S. (1984) Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 12:1-16.
14. 2 receptor antagonist, ritanserin. J. Neurochem., 59:1459-1466.
15. Dewey, S.L., Smith, G.S., Logan, J., Alexoff, D., Ding, Y.S., King, P., Pappas, N., Brodie, J.D., and Ashby, C.R. (1995) Serotonergic modulation of striatal dopamine measured with positron emission topography (PET) and in vivo microdialysis. J. Neurosci., 15: 821-829.
16. 2/1C antagonist, and negative symptoms in schizophrenia A placebo-controlled double-blind study. Br. J. Psychiatry, 163:451-455.
17. Ellenbroek, B.A., Prinssen, E.P.M., and Cools, A.R. (1994) The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats. Eur. J. Neurosci., 6:1-8.
18. Ennis, C., Kemp, J.D., and Cox, B. (1981) Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J. Neurochem., 36:1515-1520.
19. Fink-Jensen, A., Hansen, L., Nielsen, P.G., and Nielsen, E.B. (1993) Clozapine, risperidone and sertindole preferentially increase interstitial DOPAC levels in the rat prefrontal cortex relative to dorsolateral striatum. Proc. of Society for Neuroscience, 19:81.
20. 2 receptors throughout the rat central nervous system using quantitative autoradiography. Brain Res., 421:263-279.
21. Galloway, M.P., Suchowski, C.S., Keegan, M.J., and Hjorth, S. (1993) Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse, 15:90-92.
22. Grenhoff, J., Tung, C., Ugedo, L., and Svensson, T.H. (1990) Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons in vivo. Pharmacol. Toxicol., 66(Suppl. 1):29-33.
23. Gustafsson, B., and Christensson, E. (1990) Amperozide-a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour. Pharmacol. Toxicol., 66(SUppl. 1):12-17.
24. Hetey, L., and Drescher, K. (1986) Influence of antipsychotics on presynaptic receptors modulating the release of dopamine in synaptosomes of the nucleus accumbens of rats. Neuropharmacology, 25: 1103-1109.
25. Hoffman, I.S., Talmaciu, R.K., Feroo, C.P., and Cubeddu, L.X. (1988) Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal dopamine terminals. J. Pharmacol. Exp. Ther., 245:761-772.
26. 3 receptors control dopamine release in the nucleus accumbens of freely-moving rats. Neurosci. Lett., 101:214-217.
27. Imperato, A., Puglisi-Allegra, S., Zocchi, A., Scrocco, M.G., Casolini, P., and Angelucci, L. (1990) Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam. Eur. J. Pharmacol., 175:211-214.
28. Invernizzi, R., Belli, S., and Samanin, R. (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res., 584:322-324.
29. Jiang, L.H., Ashby, C.R., Kasser, R.J., and Wang, R.Y. (1990) The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study. Brain Res., 513:156-160.
30. 3H]dopamine release from the fish retina. J. Neurochem., 39:493-498.
31. 2 antagonist MDL 100,907 in animal behavioural models of drug-induced hyperactivity or disrupted prepulse inhibition. Schizophr. Res., 9:240.
32. Kilpatrick, G.J., Jones, B.J., and Tyers, M.B. (1987) Identification and distribution of 5-H3 receptors in rat brain using radioligand binding. Nature 330:746-748.
33. 2 receptor antagonist amperozide attenuates 1-2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior. Eur. J. Pharmacol., 212:241-246.
34. Leysen, J.E., Geerts, R., Gommeren, W., Verwimp, M., and Van Gompel, P. (1982) Regional distribution of serotonin-2 receptor binding sites in the brain and effects of neuronal lesions. Arch. Int. Pharmacodyn., 256:301-305.
35. 2 (S2)-receptor-binding sites: Effects of neuronal lesions. In: CNS Receptors-From Molecular Pharmacology to Behavior. P. Mandel and F.V. DeFeudis, eds. Raven Press, New York, pp. 373-383.
36. 2 pKi values. J. Pharmacol. Exp. Ther., 251:238-246.
37. 2 receptor occupancy: Implications for antipsychotic action. Eur. J. Pharmacol., 216:67-71.
38. Moghaddam, B., and Bunney, B.S. (1989) Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J. Neurochem., 53:652-657.
39. Moghaddam, B., and Bunney, B.S. (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study. J. Neurochem., 54:1755-1760.
40. 2 receptors in the rat brain. Neuroscience, 54:701-717.
41. 2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. Eur. J. Pharmacol., 153:89-95.
42. Nomikos, G.G., and Spyraki, C. (1988) Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats. Pharmacol. Biochem. Behav., 30:853-858.
43. Nomikos, G.G., Damsma, G., Wenkstern, D., and Fibiger, H.C. (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse, 6:106-112.
44. Nomikos, G.G., Iurlo, M., Andersson, J.L., Kimura, K., and Svensson, T.H. (1994) Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat prefrontal cortex. Psychopharmacology, 115:147-156.
45. Parsons, L.H., and Justice, J.B. (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res., 606:195-199.
46. Paxinos, G., and Watson, C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
47. Pazos, A., Cortes, R., and Palacios, J.M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II, Serotonin-2 receptors. Brain Res., 346:231-249.
48. Pehek, E.A., and Yamamoto, B.K. (1994) Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J. Neurochem., 63: 2118-2124.
49. Pehek, E.A., Meltzer, H.Y., and Yamamoto, B.K. (1993) The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux. Eur. J. Pharmacol., 240:107-109.
50. 3H]dopamine. Eur. J. Pharmacol., 167:309-310.
51. 2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur. J. Pharmacol., 273:273-279.
52. Schmidt, C.J., Fadayel, G.M., Ring, S.C., and Taylor, V.L. (1995) 5-HT2A receptor-mediated regulation of cortical and subcortical dopaminergic systems: Studies with the selective antagonist, MDL 100,907. Schizophr. Res., 15:164.
53. Schreiber, R., Brocco, M., and Millan, M.J. (1994) Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur. J. Pharmacol., 264:99-102.
54. Sorensen, S.M., Kehne, J.H., Fadayel, G.M., Humphreys, T.M., Ketteler, H.J., Sullivan, C.K., Taylor, V.L., and Schmidt, C.J. (1993) Characterization of the 5-HT2 receptor antagonist, MDL 100907, as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. J. Pharmacol. Exp. Ther., 266:1-8.
55. Ugedo, L., Grenhoff, J., and Svensson, T.H. (1989) Ritanserin, a 5-HT2 antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98:45-50.
56. 3H]dopamine by serotonin from superfused rat striatal slices. Neurosci. Lett., 28:205-209.
57. Wolf, M.E., Deuten, A.Y., and Roth, R.H. (1987) Pharmacology of central dopaminergic neurons. In: Handbook of Schizophrenia, Vol. 2: Neurochemistry and Neuropharmacology of Schizophrenia. F.A. Henn and L.E. DeLisi, eds. Elsevier Science Publishers, New York pp. 101-147.
58. 3 receptors attenuates the effects of ethanol on extracellular dopamine. Eur. J. Pharmacol., 187:287-289.
59. Yadid, G., Pacak, K., Kopin, I.J., and Goldstein, D.S. (1994) Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther., 270:1158-1165.
60. Yamamoto, B.K., and Davy, S. (1992) Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem., 58:1736-1742.
61. Yamamoto, B.K., and Pehek, E.A. (1990) A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res., 506:236-242.
62. Yamamoto, B.K., Pehek, E.A., and Meltzer, H.Y. (1994) Brain region effects of clozapine on amino acid and monoamine transmission. J. Clin. Psychiatry, 55:8-14.
63. +-evoked dopamine release from rat olfactory tubercle and striatal slices. Br. J. Pharmacol., 113:968-972.